Clinical trial
Residual Pulmonary Vascular Obstruction (RPVO) Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism (VTE) Recurrence in Patients With Pulmonary Embolism (PE)
NCT06372730 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Residual Pulmonary Vascular Obstruction (RPVO) Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism (VTE) Recurrence in Patients With Pulmonary Embolism (PE)
- Lead sponsor
- University Hospital, Brest
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 11, 2024
- Completion date
- March 31, 2029
- Enrollment
- 665 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.